Essex Woodlands Management as of March 31, 2018
Portfolio Holdings for Essex Woodlands Management
Essex Woodlands Management holds 9 positions in its portfolio as reported in the March 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Axogen (AXGN) | 29.6 | $136M | 3.7M | 36.50 | |
| Revance Therapeutics (RVNC) | 25.9 | $118M | 3.8M | 30.80 | |
| Corium Intl | 23.5 | $107M | 9.4M | 11.47 | |
| Abiomed | 12.8 | $59M | 202k | 290.99 | |
| MediciNova (MNOV) | 2.6 | $12M | 1.2M | 10.22 | |
| Endologix | 2.5 | $12M | 1.3M | 9.21 | |
| pSivida | 2.3 | $11M | 8.6M | 1.22 | |
| Catalyst Biosciences | 0.5 | $2.1M | 79k | 26.84 | |
| Acura Pharmaceuticals (ACUR) | 0.2 | $998k | 2.0M | 0.51 |
